page-template-default,page,page-id-275,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,qode-theme-ver-14.3,qode-theme-bridge,disabled_footer_top,wpb-js-composer js-comp-ver-5.4.7,vc_responsive


What is CRSCM?


CRSCM is a national coalition of non-profits, healthcare organizations, businesses, researchers, professional associations, disease advocacy groups and concerned citizens dedicated to educating the general public and policymakers on the therapeutic potential of newborn stem cells, the unique stem cells that can be collected immediately following birth from umbilical cord blood and the cord itself, as well as helping to advance the use of one’s own newborn stem cells in regenerative medicine.


What is Regenerative Medicine?


Regenerative medicine is the next evolution of medical treatments that focuses on using the body’s own stem cells to cure failing, impaired or injured tissues. According to the U.S. Department of Health and Human Services, this revolutionary approach to medicine has the potential to develop therapies for previously untreatable diseases and conditions. Research is exploring the use of cord blood stem cells as potential treatment for cerebral palsy, brain damage from accidents, stroke, spinal cord injuries, diabetes, heart disease, and renal failure.


How Are Newborn Stem Cells Being Used in Medical Treatments Today?


Newborn stem cells from umbilical cord blood have been used in more than 15,000 transplants worldwide during the last 20 years to treat more than 70 diseases in both adults and children. Cord blood stem cells are safe, effective, approved for therapeutic use and have unique characteristics compared with other sources of stem cells. Today, human clinical studies involving the use of one’s own cord blood stem cells are exploring treatment for diabetes, brain damage, spinal cord injuries, hearing loss and other regenerative therapies.


Who Should Join CRSCM and Why?


Any entity, regardless of size, sector, or geographic location that supports the CRSCM mission should join the coalition. Regenerative therapies are the future of medicine and the use of one’s own cord blood provides a source of unique stem cells and a safe approach for researching new therapies. Joining CRSCM will give you or your organization the ability to play a leading and active role in advancing stem cell science and your voice will help CRSCM advocate for measures that increase access to cord blood banking and create greater awareness of cord blood’s use in regenerative medicine.


How Much Does it Cost To Join CRSCM and to What Am I Committing By Joining?


There are no fees or shared costs for membership in CRSCM.


By joining CRSCM, you are allowing the coalition to list your organization’s name on its roster of members as a supporter of the coalition’s mission. Any other use of your organization’s name would require your prior approval. For members who are so inclined, there will be numerous opportunities (joint letters, meetings, special events, etc.) for coalition members to actively promote the impact that greater utilization of cord blood banking will have on healthcare and disease before Congress, the media, and the American public.


Where Does CRSCM Stand on Federal Legislation?


CRSCM believes that federal legislation is needed to educate expectant women about cord blood banking and to allow families to use tax-free dollars to make cord blood banking more affordable. The coalition has currently endorsed two federal bills including the Family Cord Blood Banking Act (H.R. 1718), which will allow families to use tax advantaged health dollars for qualified cord blood banking services, and the “Cord Blood Education and Awareness Act of 2009” (H.R. 2107), which will emplace national education on cord blood banking options and standardize informed consent on cord blood stem cells for pregnant women.


The coalition will not take positions on local ordinances or state legislation.


Where does CRSCM stand on Embryonic Stem Cells?


CRSCM remains neutral on the issue of embryonic stem cells. The coalition is singularly focused on the use of cord blood stem cells in regenerative medicine and will take no position on embryonic stem cells.